Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Chronic Myeloid Leukemia
3 articles
ASC2ESCALATE: Exploring Asciminib's Potential in Early-Stage CML Treatment
Phase II trial evaluates asciminib for first- and second-line therapy in chronic myeloid leukemia.
New Analysis Supports Flexible Dosing Options for CML Drug Asciminib
Study shows similar efficacy and safety for once-daily and twice-daily asciminib dosing in CML patients.
Fosfomycin vs Ciprofloxacin: A New Approach to Prevent Infections in High-Risk Blood Cancer Patients
Study compares fosfomycin to ciprofloxacin for preventing infections in leukemia and transplant patients